col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Journal of Neurology
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―27 Covid-19 and Parkinson’s disease: an overview S. M. Cartella, C. Terranova, V. Rizzo, A. Quartarone, P. Girlanda
2 [GO] 2021―Jul―24 Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events C. O´Sullivan, F. Zach, T. Moser, G. Pilz, A. Harrer, E. Trinka, et al. (+3)
3 [GO] 2021―Jul―21 Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature Francesco Motolese, Mario Ferrante, Mariagrazia Rossi, Alessandro Magliozzi, Martina Sbarra, Francesca Ursini, et al. (+6)
4 [GO] 2021―Jul―03 COVID-19 and Parkinson’s disease: a casual association or a possible second hit in neurodegeneration? Francesco Cavallieri, Valentina Fioravanti, Giulia Toschi, Sara Grisanti, Manuela Napoli, Claudio Moratti, et al. (+9)
5 [GO] 2021―Jun―29 Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience Guerrieri S., Lazzarin S., Zanetta C., Nozzolillo A., Filippi M., Moiola L.
6 [GO] 2021―Jun―15 Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2 Christoph Helmchen, Gesine M. Buttler, Robert Markewitz, Katja Hummel, Heinz Wiendl, Tobias Boppel
7 [GO] 2021―Jun―11 First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine Joachim Havla, Yannick Schultz, Hanna Zimmermann, Reinhard Hohlfeld, Adrian Danek, Tania Kümpfel
8 [GO] 2021―Jun―11 Global survey on disruption and mitigation of neurological services during COVID-19: the perspective of global international neurological patients and scientific associations Chahnez Charfi Triki, Matilde Leonardi, Salma Zouari Mallouli, Martina Cacciatore, Kimberly Coard Karlshoej, Francesca Giulia Magnani, et al. (+9)
9 [GO] 2021―Jun―03 Altered mental status in COVID-19 Daniel Antoniello, Mark J. Milstein, Joseph Dardick, Jenelys Fernandez-Torres, Jenny Lu, Nikunj Patel, Charles Esenwa
10 [GO] 2021―Jun―03 Impact of the COVID-19 lockdown on the adherence of stroke patients to direct oral anticoagulants: a secondary analysis from the MAAESTRO study Fine Dietrich, Alexandros A. Polymeris, Melina Verbeek, Stefan T. Engelter, Kurt E. Hersberger, Sabine Schaedelin, et al. (+2)
11 [GO] 2021―May―25 Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report C. Martin-Villares, A. Vazquez-Feito, M. J. Gonzalez-Gimeno, B. de la Nogal-Fernandez
12 [GO] 2021―May―24 SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy Alessandro Pezzini, Mario Grassi, Giorgio Silvestrelli, Martina Locatelli, Nicola Rifino, Simone Beretta, et al. (+42)
13 [GO] 2021―May―22 Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review David García-Azorín, Katrin M. Seeher, Charles R. Newton, Njideka U. Ok뫞jo, Andrea Pilotto, Deanna Saylor, et al. (+3)
14 [GO] 2021―May―22 Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis Tilmann Graf, Thomas Thiele, Randolf Klingebiel, Andreas Greinacher, Wolf-Rüdiger Schäbitz, Isabell Greeve
15 [GO] 2021―May―19 COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2 Shitiz Sriwastava, Medha Tandon, Sanjiti Podury, Apoorv Prasad, Sijin Wen, Garret Guthrie, et al. (+5)
16 [GO] 2021―May―18 Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung Gaetano Bulfamante, Tommaso Bocci, Monica Falleni, Laura Campiglio, Silvia Coppola, Delfina Tosi, et al. (+2)
17 [GO] 2021―May―17 Navigating migraine care through the COVID-19 pandemic: an update Heather Angus-Leppan, Angelica E. Guiloff, Karen Benson, Roberto J. Guiloff
18 [GO] 2021―May―10 Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients Rebecca De Lorenzo, Nicola I. Loré, Annamaria Finardi, Alessandra Mandelli, Daniela M. Cirillo, Cristina Tresoldi, et al. (+7)
19 [GO] 2021―May―05 The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder Faraidoon Haghdoost, Cheryl Carcel, Deepak Chandrasekhar, Anthony Rodgers, Candice Delcourt
20 [GO] 2021―May―03 Neurological and cognitive sequelae of Covid-19: a four month follow-up Flavia Mattioli, Chiara Stampatori, Francesca Righetti, Emma Sala, Cesare Tomasi, Giuseppe De Palma
21 [GO] 2021―Apr―30 Neurological update: COVID-19 A. L. Ren, R. J. Digby, E. J. Needham
22 [GO] 2021―Apr―29 Intraluminal carotid thrombosis and acute ischemic stroke associated with COVID-19 Diaa Hamouda, Dinesh V. Jillella, Nirav Bhatt, Sitara Koneru, Michael R. Frankel, Raul G. Nogueira
23 [GO] 2021―Apr―28 Spontaneous spinal cord ischemia during COVID-19 infection Francesco Bax, Gian Luigi Gigli, Francesca Iaiza, Mariarosaria Valente
24 [GO] 2021―Apr―27 COVID-19 in a patient treated with eculizumab for aquaporin-4 neuromyelitis optica Ana Maria Cabal-Herrera, Farrah J. Mateen
25 [GO] 2021―Apr―25 Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19 Tobias Geis, Susanne Brandstetter, Antoaneta A. Toncheva, Otto Laub, Georg Leipold, Ralf Wagner, et al. (+4)
26 [GO] 2021―Apr―21 SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients Mauro Morassi, Francesco Palmerini, Stefania Nici, Eugenio Magni, Giordano Savelli, Ugo Paolo Guerra, et al. (+3)
27 [GO] 2021―Apr―19 Neurosensory dysphagia in a COVID-19 patient Alessia Zanon, Laura Cacciaguerra, Gabriele Martelli, Massimo Filippi
28 [GO] 2021―Apr―16 Comment on the paper Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab: the likely explanation for this phenomenon based on our observations Hubert Mado, Monika Adamczyk-Sowa
29 [GO] 2021―Apr―15 Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? Mario Orrico, Agostino Nozzolillo, Stefano Gelibter, Francesca Sangalli, Paolo Preziosa, Massimo Filippi, Lucia Moiola
30 [GO] 2021―Apr―12 Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus Diego Centonze, Maria A. Rocca, Claudio Gasperini, Ludwig Kappos, Hans-Peter Hartung, Melinda Magyari, et al. (+4)
31 [GO] 2021―Apr―08 Palilalia as a prominent feature of anti-NMDA receptor encephalitis in a woman with COVID-19 Andrew W. McHattie, Jan Coebergh, Faraan Khan, Francesca Morgante
32 [GO] 2021―Apr―01 Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection Kuntal Sen, Dana Harrar, Andrea Hahn, Elizabeth M. Wells, Andrea L. Gropman
33 [GO] 2021―Mar―20 Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19 Anne Hege Aamodt, Einar August Høgestøl, Trine Haug Popperud, Jan Cato Holter, Anne Ma Dyrhol-Riise, Kristian Tonby, et al. (+9)
34 [GO] 2021―Mar―18 Brainstem clinical and neurophysiological involvement in COVID-19 Tommaso Bocci, Gaetano Bulfamante, Laura Campiglio, Silvia Coppola, Monica Falleni, Davide Chiumello, Alberto Priori
35 [GO] 2021―Mar―17 Could symptom overlap of COVID-19 and Guillain-Barré syndrome mask an epidemiological association? Martin K. R. Svačina, Felix Kohle, Alina Sprenger, Helmar C. Lehmann
36 [GO] 2021―Mar―15 Neurology and vaccinations: considerations in the context of COVID-19/SARS-COV-2 M. Cauchi, N. P. Robertson
37 [GO] 2021―Mar―11 Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients Paolo Manganotti, Giovanni Furlanis, Miloš Ajčević, Cristina Moras, Lucia Bonzi, Valentina Pesavento, Alex Buoite Stella
38 [GO] 2021―Mar―08 Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network Alessandro Pezzini, Mario Grassi, Giorgio Silvestrelli, Martina Locatelli, Nicola Rifino, Simone Beretta, et al. (+42)
39 [GO] 2021―Feb―27 Hospital admissions of acute cerebrovascular diseases during and after the first wave of the COVID-19 pandemic: a state-wide experience from Austria Thomas Gattringer, Simon Fandler-Höfler, Markus Kneihsl, Edith Hofer, Wolfgang Köle, Reinhold Schmidt, et al. (+3)
40 [GO] 2021―Feb―27 Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab Mahsa Khayat-Khoei, Sarah Conway, Douglas A. Rubinson, Petr Jarolim, Maria K. Houtchens
41 [GO] 2021―Feb―22 Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review Jason L. Chan, Keely A. Murphy, Justyna R. Sarna
42 [GO] 2021―Feb―22 Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review Vahid Reza Ostovan, Razieh Foroughi, Mahtab Rostami, Mostafa Almasi-Dooghaee, Manouchehr Esmaili, Ali Akbar Bidaki, et al. (+18)
43 [GO] 2021―Feb―21 Bell’s palsy following COVID-19 vaccination Giuseppe Colella, Massimiliano Orlandi, Nicola Cirillo
44 [GO] 2021―Feb―20 COVID-19 in multiple sclerosis patients treated with dimethyl fumarate Fioravante Capone, Elisabetta Ferraro, Francesco Motolese, Vincenzo Di Lazzaro
45 [GO] 2021―Feb―19 Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms V. A. Blanco-Palmero, F. J. Azcárate-Díaz, M. Ruiz-Ortiz, M. I. Laespada-García, P. Rábano-Suárez, A. Méndez-Guerrero, et al. (+7)
46 [GO] 2021―Feb―19 COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy Eveline Van Looy, Len Veenker, Aurelia Steyaert, Jo Leenders, Goedele Malfroid, Harald De Cauwer
47 [GO] 2021―Feb―08 Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data R. Beyrouti, J. G. Best, A. Chandratheva, R. J. Perry, D. J. Werring
48 [GO] 2021―Feb―04 Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19 Ulrich Hofstadt-van Oy, Slobodan Stankovic, Corinna Kelbel, Daniel Oswald, Simon Larrosa-Lombardi, Thomas Barchfeld, Ulrich Cleff
49 [GO] 2021―Jan―23 Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) Biyan Nathanael Harapan, Hyeon Joo Yoo
50 [GO] 2021―Jan―13 Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up Vardan Nersesjan, Moshgan Amiri, Anne-Mette Lebech, Casper Roed, Helene Mens, Lene Russell, et al. (+15)
51 [GO] 2021―Jan―02 COVID-19 in children with neuromuscular disorders Daniel Natera-de Benito, Sergio Aguilera-Albesa, Laura Costa-Comellas, Mar García-Romero, María Concepción Miranda-Herrero, Júlia Rúbies Olives, et al. (+9)
52 [GO] 2021―Jan―02 SARS-CoV-2 infection in patients with primary central nervous system lymphoma Alice Laurenge, Renata Ursu, Caroline Houillier, Basma Abdi, Gianpiero Tebano, Cyril Quemeneur, et al. (+19)
53 [GO] 2020―Nov―26 Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19 Edward Needham, Virginia Newcombe, Andrew Michell, Rachel Thornton, Andrew Grainger, Fahim Anwar, et al. (+4)
54 [GO] 2020―Nov―21 Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses François Lersy, Thibault Willaume, Jean-Christophe Brisset, Olivier Collange, Julie Helms, Francis Schneider, et al. (+6)
55 [GO] 2020―Nov―20 COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience Paolo Preziosa, Maria A. Rocca, Agostino Nozzolillo, Lucia Moiola, Massimo Filippi
56 [GO] 2020―Nov―20 Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up Julia V. Wanschitz, Manuela Kaml, Bettina Pfausler, Raimund Helbok, Sophie Wildner, Gerlig Widmann, et al. (+6)
57 [GO] 2020―Oct―30 Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature Federico Cagnazzo, Caroline Arquizan, Imad Derraz, Cyril Dargazanli, Pierre-Henri Lefevre, Carlos Riquelme, et al. (+5)
58 [GO] 2020―Oct―26 Management of Parkinson's disease patients after DBS by remote programming: preliminary application of single center during quarantine of 2019-nCoV Jinyu Xu, Jiali Wang, Simfukwe Keith, Mingyang Zhang, Chunhui Yang, Qing Yuan, et al. (+3)
59 [GO] 2020―Oct―26 The neurological sequelae of pandemics and epidemics Fernanda Valerio, Daniel P. Whitehouse, David K. Menon, Virginia F. J. Newcombe
60 [GO] 2020―Oct―24 COVID-19 in Parkinson’s disease: what holds the key? R. Sainz-Amo, B. Baena-Álvarez, I. Pareés, G. Sánchez-Díez, P. Pérez-Torre, J. L. López-Sendón, et al. (+7)
61 [GO] 2020―Oct―20 Correction to: The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland Stella A. Glasmacher, Juan Larraz, Arpan R. Mehta, Patrick K. A. Kearns, Michael Wong, Judith Newton, et al. (+6)
62 [GO] 2020―Oct―12 New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review Shitiz Sriwastava, Medha Tandon, Saurabh Kataria, Maha Daimee, Shumaila Sultan
63 [GO] 2020―Oct―08 Intravenous immunoglobulin therapy in COVID-19-related encephalopathy Lorenzo Muccioli, Umberto Pensato, Giorgia Bernabè, Lorenzo Ferri, Maria Tappatà, Lilia Volpi, et al. (+14)
64 [GO] 2020―Oct―07 Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy Nicola Rifino, Bruno Censori, Emanuela Agazzi, Dario Alimonti, Virginio Bonito, Giorgia Camera, et al. (+18)
65 [GO] 2020―Sep―22 A word of hope for ataxia trials in COVID-19 time and beyond Roderick P. P. W. M. Maas, Jordache Ramjith, Thomas Klockgether, Kit C. B. Roes, Bart P. C. van de Warrenburg
66 [GO] 2020―Sep―20 Stroke care in Italy at the time of the COVID-19 pandemic: a lesson to learn Anna Bersano, Leonardo Pantoni
67 [GO] 2020―Sep―17 A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection Fabio Giuseppe Masuccio, Massimo Barra, Geda Claudio, Solaro Claudio
68 [GO] 2020―Sep―12 COVID-19 infection in NMO/SD patients: a French survey Sinéad Zeidan, Elisabeth Maillart, Céline Louapre, Thomas Roux, Catherine Lubetzki, Caroline Papeix
69 [GO] 2020―Sep―10 Acute new-onset symptomatic seizures in the context of mild COVID-19 infection Maria Gaughan, Sean Connolly, Shamindra Direkze, Justin A. Kinsella
70 [GO] 2020―Sep―10 Effect of the COVID-19 pandemic on acute stroke reperfusion therapy: data from the Lyon Stroke Center Network Cécile Plumereau, Tae-Hee Cho, Marielle Buisson, Camille Amaz, Matteo Cappucci, Laurent Derex, et al. (+15)
71 [GO] 2020―Sep―10 Spinal epidural abscess in COVID-19 patients G. Talamonti, Davide Colistra, Francesco Crisà, Marco Cenzato, Pietro Giorgi, Giuseppe D’Aliberti
72 [GO] 2020―Sep―05 Correction to: Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis Urvish Patel, Preeti Malik, Dhaivat Shah, Achint Patel, Mandip Dhamoon, Vishal Jani
73 [GO] 2020―Sep―05 The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland Stella A. Glasmacher, Juan Larraz, Arpan R. Mehta, Patrick K. A. Kearns, Michael Wong, Judith Newton, et al. (+6)
74 [GO] 2020―Sep―03 Bickerstaff encephalitis after COVID-19 Lucía Llorente Ayuso, Pedro Torres Rubio, Rafael Fernando Beijinho do Rosário, María Luisa Giganto Arroyo, Fernando Sierra-Hidalgo
75 [GO] 2020―Sep―03 Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region Eleonora Del Prete, Alessio Francesconi, Giovanni Palermo, Sonia Mazzucchi, Daniela Frosini, Riccardo Morganti, et al. (+15)
76 [GO] 2020―Sep―03 Parainfectious encephalitis in COVID-19: “The Claustrum Sign” Frédéric Zuhorn, Hassan Omaimen, Bertram Ruprecht, Christoph Stellbrink, Michael Rauch, Andreas Rogalewski, et al. (+2)
77 [GO] 2020―Sep―01 Why do SARS-CoV-2 NSPs rush to the ER? Maryline Santerre, Sterling P. Arjona, Charles NS Allen, Natalia Shcherbik, Bassel E. Sawaya
78 [GO] 2020―Aug―31 Mild COVID-19 infection in a group of teriflunomide-treated patients with multiple sclerosis Vittorio Mantero, Damiano Baroncini, Roberto Balgera, Clara Guaschino, Paola Basilico, Pietro Annovazzi, et al. (+3)
79 [GO] 2020―Aug―27 COVID-19: dealing with a potential risk factor for chronic neurological disorders Tommaso Schirinzi, Doriana Landi, Claudio Liguori
80 [GO] 2020―Aug―25 Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases Samir Abu-Rumeileh, Ahmed Abdelhak, Matteo Foschi, Hayrettin Tumani, Markus Otto
81 [GO] 2020―Aug―19 The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis Nancy D. Chiaravalloti, Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Ulrik Dalgas, John DeLuca, et al. (+12)
82 [GO] 2020―Aug―19 How important are the team dynamics in the battle against COVID-19? Kajal Ruparell
83 [GO] 2020―Aug―18 Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection Anthony Moreau, Amedee Ego, Frederic Vandergheynst, Fabio Silvio Taccone, Niloufar Sadeghi, Isabel Montesinos, et al. (+2)
84 [GO] 2020―Aug―17 Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic Gianluca Costamagna, Elena Abati, Nereo Bresolin, Giacomo Pietro Comi, Stefania Corti
85 [GO] 2020―Aug―14 Severe neurological complications in critically ill COVID-19 patients Quirin Notz, Christopher Lotz, Johannes Herrmann, Marius Vogt, Tobias Schlesinger, Markus Kredel, et al. (+5)
86 [GO] 2020―Aug―09 Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient Catalina Maideniuc, Anza B. Memon
87 [GO] 2020―Aug―08 Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis Urvish Patel, Preeti Malik, Dhaivat Shah, Achint Patel, Mandip Dhamoon, Vishal Jani
88 [GO] 2020―Aug―08 SARS-CoV-2 associated Guillain-Barré syndrome Teodor Pelea, Ursula Reuter, Christine Schmidt, Raimondo Laubinger, Robert Siegmund, Bjoern Wito Walther
89 [GO] 2020―Aug―07 Neurological features in SARS-CoV-2-infected patients with smell and taste disorder Antoniangela Cocco, Paolo Amami, Antonio Desai, Antonio Voza, Fabio Ferreli, Alberto Albanese
90 [GO] 2020―Aug―06 Association of history of cerebrovascular disease with severity of COVID-19 Timo Siepmann, Annahita Sedghi, Jessica Barlinn, Katja de With, Lutz Mirow, Martin Wolz, et al. (+16)
91 [GO] 2020―Aug―06 Neurological manifestations in 404 COVID-19 patients in Washington State Pinky Agarwal, Sudeshna Ray, Arina Madan, Brad Tyson
92 [GO] 2020―Aug―04 Neurological comorbidity and severity of COVID-19 Alberto Romagnolo, Roberta Balestrino, Gabriele Imbalzano, Giovannino Ciccone, Franco Riccardini, Carlo Alberto Artusi, et al. (+8)
93 [GO] 2020―Aug―04 Reply to "Guillain-Barré syndrome in the COVID-19 era another occasional cluster?": Insights from two distinct clusters of Guillain-Barré syndrome detected in Europe in the COVID-19 era Alessandro Marini, Alberto Vogrig, Francesco Bax, Gaia Pellitteri, Andrea Surcinelli, Mariarosaria Valente, Gian Luigi Gigli
94 [GO] 2020―Aug―01 Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature Davide Tiziano Di Carlo, Nicola Montemurro, Giandomenico Petrella, Gabriele Siciliano, Roberto Ceravolo, Paolo Perrini
95 [GO] 2020―Aug―01 Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research Alberto Vogrig, Daniele Bagatto, Gian Luigi Gigli, Milena Cobelli, Serena D’Agostini, Claudio Bnà, Mauro Morassi
96 [GO] 2020―Jul―30 Immune-mediated neurological syndromes in SARS-CoV-2-infected patients Antoine Guilmot, Sofia Maldonado Slootjes, Amina Sellimi, Maroussia Bronchain, Bernard Hanseeuw, Leila Belkhir, et al. (+16)
97 [GO] 2020―Jul―28 Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? Rocco Capuano, Manuela Altieri, Alvino Bisecco, Alessandro d’Ambrosio, Renato Docimo, Daniela Buonanno, et al. (+5)
98 [GO] 2020―Jul―25 Comment on “Stroke in patients with SARS-CoV-2 infection: case series” from a London hospital experience Anan Shtaya, Sarah Trippier, Rita Ghatala, Gillian Cluckie, Liqun Zhang
99 [GO] 2020―Jul―21 COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? Luigi Ferini-Strambi, Maria Salsone
100 [GO] 2020―Jul―21 Amyotrophic lateral sclerosis patients’ and caregivers' distress and loneliness during COVID-19 lockdown Monica Consonni, Alessandra Telesca, Eleonora Dalla Bella, Enrica Bersano, Giuseppe Lauria
101 [GO] 2020―Jul―20 Excess neurological death in New York City after the emergence of COVID-19 Adam de Havenon, John P. Ney, Brian Callaghan, Shadi Yaghi, Jennifer J. Majersik
102 [GO] 2020―Jul―20 A systematic review of neurological symptoms and complications of COVID-19 Xiangliang Chen, Sarah Laurent, Oezguer A. Onur, Nina N. Kleineberg, Gereon R. Fink, Finja Schweitzer, Clemens Warnke
103 [GO] 2020―Jul―20 Impact of the COVID-19 outbreak on acute stroke care L. A. Rinkel, J. C. M. Prick, R. E. R. Slot, N. M. A. Sombroek, J. Burggraaff, A. E. Groot, et al. (+10)
104 [GO] 2020―Jul―18 Isolated post SARS-CoV-2 diplopia Thiago Gonçalves dos Santos Martins
105 [GO] 2020―Jul―16 Not only pulmonary rehabilitation for critically ill patients with COVID-19 Anna Estraneo, Marco Ciapetti, Carlo Gaudiosi, Antonello Grippo
106 [GO] 2020―Jul―13 Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine Vincenzo Di Stefano, Giuseppe Battaglia, Valerio Giustino, Andrea Gagliardo, Michele D’Aleo, Ottavio Giannini, et al. (+2)
107 [GO] 2020―Jul―11 Frontal encephalopathy related to hyperinflammation in COVID-19 Ilaria Cani, Valentina Barone, Roberto D’Angelo, Lara Pisani, Vincenzo Allegri, Luca Spinardi, et al. (+6)
108 [GO] 2020―Jul―11 Impact of COVID-19 lockdown on sleep quality in university students and administration staff Sara Marelli, Alessandra Castelnuovo, Antonella Somma, Vincenza Castronovo, Samantha Mombelli, Daniela Bottoni, et al. (+3)
109 [GO] 2020―Jul―11 Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients Marcel S. Woo, David Steins, Vivien Häußler, Matin Kohsar, Friedrich Haag, Birte Elias-Hamp, et al. (+4)
110 [GO] 2020―Jul―10 Telemedicine for neuromuscular disorders during the COVID-19 outbreak Matteo Garibaldi, Gabriele Siciliano, Giovanni Antonini
111 [GO] 2020―Jul―09 Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19 Markus Ameres, Susanne Brandstetter, Antoaneta A. Toncheva, Michael Kabesch, David Leppert, Jens Kuhle, Sven Wellmann
112 [GO] 2020―Jul―07 Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role? Vittorio Mantero, Andrea Rigamonti, Paola Basilico, Marta Crespi, Roberto Balgera, Andrea Salmaggi
113 [GO] 2020―Jul―07 Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices Farrah J. Mateen, Shawheen Rezaei, Nicholas Alakel, Brittany Gazdag, Aditya Ravi Kumar, Andre Vogel
114 [GO] 2020―Jul―07 COVID-19 reveals influence of physical activity on symptom severity in hereditary spastic paraplegia Lotte van de Venis, Bart P. C. van de Warrenburg, Vivian Weerdesteyn, Bas J. H. van Lith, Alexander C. H. Geurts, Jorik Nonnekes
115 [GO] 2020―Jun―29 Transverse myelitis related to COVID-19 infection Alexandros Zachariadis, Anca Tulbu, Davide Strambo, Alexis Dumoulin, Gabriella Di Virgilio
116 [GO] 2020―Jun―29 What has caused the fall in stroke admissions during the COVID-19 pandemic? Richard Perry, Azra Banaras, David J. Werring, Robert Simister
117 [GO] 2020―Jun―27 Large artery ischemic stroke in severe COVID-19 Fernando Sierra-Hidalgo, Nuria Muñoz-Rivas, Pedro Torres Rubio, Kateri Chao, Mercedes Villanova Martínez, Paz Arranz García, Eva Martínez-Acebes
118 [GO] 2020―Jun―25 COVID-19 in dimethyl fumarate-treated patients with multiple sclerosis Vittorio Mantero, Lucia Abate, Paola Basilico, Roberto Balgera, Andrea Salmaggi, Bardia Nourbakhsh, Christian Cordano
119 [GO] 2020―Jun―25 Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2 Martina Bracaglia, Ilaria Naldi, Alessandra Govoni, Donatella Brillanti Ventura, Patrizia De Massis
120 [GO] 2020―Jun―24 Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient Lucia Princiotta Cariddi, Payam Tabaee Damavandi, Federico Carimati, Paola Banfi, Alessandro Clemenzi, Margherita Marelli, et al. (+4)
121 [GO] 2020―Jun―24 Characteristics and clinical course of Covid-19 patients admitted with acute stroke Lucio D’Anna, Joseph Kwan, Zoe Brown, Omid Halse, Sohaa Jamil, Dheeraj Kalladka, et al. (+2)
122 [GO] 2020―Jun―23 Guillain-Barré syndrome in the COVID-19 era: another occasional cluster? Laurent Tatu, Sandra Nono, Simone Grácio, Serdar Koçer
123 [GO] 2020―Jun―20 First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease Renan Barros Domingues, Maria Cássia Mendes-Correa, Fernando Brunale Vilela de Moura Leite, Ester Cerdeira Sabino, Diego Zanotti Salarini, Ingra Claro, et al. (+5)
124 [GO] 2020―Jun―19 Neurological involvement of coronavirus disease 2019: a systematic review Malik Ghannam, Qasem Alshaer, Mustafa Al-Chalabi, Lara Zakarna, Jetter Robertson, Georgios Manousakis
125 [GO] 2020―Jun―17 Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study Giordano Cecchetti, Marco Vabanesi, Raffaella Chieffo, Giovanna Fanelli, Fabio Minicucci, Federica Agosta, et al. (+3)
126 [GO] 2020―Jun―12 Isolated post SARS-CoV-2 diplopia Alice Faucher, Pierre-Antoine Rey, Elise Aguadisch, Bertrand Degos
127 [GO] 2020―Jun―12 Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence? Mauro Morassi, Barbara Bigni, Milena Cobelli, Lodoviga Giudice, Claudio Bnà, Alberto Vogrig
128 [GO] 2020―Jun―12 Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection H. Chaumont, A. San-Galli, F. Martino, C. Couratier, G. Joguet, M. Carles, et al. (+2)
129 [GO] 2020―Jun―11 COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF Daniela Andriuta, Pierre-Alexandre Roger, William Thibault, Bénédicte Toublanc, Chloe Sauzay, Sandrine Castelain, et al. (+2)
130 [GO] 2020―Jun―11 Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis Lei Wang, Yin Shen, Man Li, Haoyu Chuang, Youfan Ye, Hongyang Zhao, Haijun Wang
131 [GO] 2020―Jun―03 A review of pathophysiology and neuropsychiatric manifestations of COVID-19 Madhu Jasti, Krishna Nalleballe, Vasuki Dandu, Sanjeeva Onteddu
132 [GO] 2020―Jun―03 COVID-19 in teriflunomide-treated patients with multiple sclerosis Amir Hadi Maghzi, Maria K. Houtchens, Paolo Preziosa, Carolina Ionete, Biljana D. Beretich, James M. Stankiewicz, et al. (+9)
133 [GO] 2020―Jun―03 Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse Nora Möhn, Firas Saker, Viktoria Bonda, Gesine Respondek, Marcus Bachmann, Matthias Stoll, et al. (+3)
134 [GO] 2020―Jun―03 Neurological complications of COVID-19: a preliminary review A. Pryce-Roberts, M. Talaei, N. P. Robertson
135 [GO] 2020―May―30 COVID-19-associated acute disseminated encephalomyelitis (ADEM) Timothy Parsons, Sarah Banks, Chay Bae, Joel Gelber, Hussein Alahmadi, Matthew Tichauer
136 [GO] 2020―May―27 Onset of Covid-19 with impaired consciousness and ataxia: a case report R. Balestrino, M. Rizzone, M. Zibetti, A. Romagnolo, C. A. Artusi, E. Montanaro, L. Lopiano
137 [GO] 2020―May―26 Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19 Kazimierz Logmin, Mohamed Karam, Tanja Schichel, Jens Harmel, Lars Wojtecki
138 [GO] 2020―May―26 Acute transverse myelitis after COVID-19 pneumonia Maike Munz, Swen Wessendorf, Georgios Koretsis, Friedemann Tewald, Reem Baegi, Stefan Krämer, et al. (+2)
139 [GO] 2020―May―26 Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms Zhiqiang Zhou, Huicong Kang, Shiyong Li, Xu Zhao
140 [GO] 2020―May―26 Neurological manifestations of COVID-19: a review of what we know so far Panagiotis Gklinos
141 [GO] 2020―May―26 Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19) Jessica Fernández-Domínguez, Elena Ameijide-Sanluis, Carmen García-Cabo, Raquel García-Rodríguez, Valentín Mateos
142 [GO] 2020―May―26 Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report Nilo Riva, Tommaso Russo, Yuri Matteo Falzone, Marta Strollo, Stefano Amadio, Ubaldo Del Carro, et al. (+3)
143 [GO] 2020―May―25 Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19) Georgios Tsivgoulis, Paraskevi C. Fragkou, Alexander Delides, Emmanouil Karofylakis, Dimitra Dimopoulou, Petros P. Sfikakis, Sotirios Tsiodras
144 [GO] 2020―May―20 Neurological manifestations associated with COVID-19: a review and a call for action Matilde Leonardi, Alessandro Padovani, Justin C. McArthur
145 [GO] 2020―May―20 Stroke in patients with SARS-CoV-2 infection: case series Mauro Morassi, Daniele Bagatto, Milena Cobelli, Serena D’Agostini, Gian Luigi Gigli, Claudio Bnà, Alberto Vogrig
146 [GO] 2020―May―19 Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster? Gian Luigi Gigli, Francesco Bax, Alessandro Marini, Gaia Pellitteri, Anna Scalise, Andrea Surcinelli, Mariarosaria Valente
147 [GO] 2020―May―12 Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19 Thomas Pfefferkorn, Rainer Dabitz, Thomas von Wernitz-Keibel, Johannes Aufenanger, Martina Nowak-Machen, Hendrik Janssen
148 [GO] 2020―May―12 Tele-health in neurology: an indispensable tool in the management of the SARS-CoV-2 epidemic Ruggero Capra, Flavia Mattioli
149 [GO] 2020―Apr―24 Guillain-Barré syndrome following COVID-19: new infection, old complication? Marina Padroni, Vincenzo Mastrangelo, Gian Maria Asioli, Lucia Pavolucci, Samir Abu-Rumeileh, Maria Grazia Piscaglia, et al. (+3)
150 [GO] 2020―Apr―17 Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2 M. D. Willis, N. P. Robertson


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.011 sec